Potent Virustatic Polymer-Lipid Nanomimics Block Viral Entry and Inhibit Malaria Parasites In Vivo
© 2022 The Authors. Published by American Chemical Society..
Infectious diseases continue to pose a substantial burden on global populations, requiring innovative broad-spectrum prophylactic and treatment alternatives. Here, we have designed modular synthetic polymer nanoparticles that mimic functional components of host cell membranes, yielding multivalent nanomimics that act by directly binding to varied pathogens. Nanomimic blood circulation time was prolonged by reformulating polymer-lipid hybrids. Femtomolar concentrations of the polymer nanomimics were sufficient to inhibit herpes simplex virus type 2 (HSV-2) entry into epithelial cells, while higher doses were needed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given their observed virustatic mode of action, the nanomimics were also tested with malaria parasite blood-stage merozoites, which lose their invasive capacity after a few minutes. Efficient inhibition of merozoite invasion of red blood cells was demonstrated both in vitro and in vivo using a preclinical rodent malaria model. We envision these nanomimics forming an adaptable platform for developing pathogen entry inhibitors and as immunomodulators, wherein nanomimic-inhibited pathogens can be secondarily targeted to sites of immune recognition.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
ACS central science - 8(2022), 9 vom: 28. Sept., Seite 1238-1257 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Najer, Adrian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 09.02.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1021/acscentsci.1c01368 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347038352 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347038352 | ||
| 003 | DE-627 | ||
| 005 | 20231226032856.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/acscentsci.1c01368 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1156.xml |
| 035 | |a (DE-627)NLM347038352 | ||
| 035 | |a (NLM)36188342 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Najer, Adrian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potent Virustatic Polymer-Lipid Nanomimics Block Viral Entry and Inhibit Malaria Parasites In Vivo |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 09.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Authors. Published by American Chemical Society. | ||
| 520 | |a Infectious diseases continue to pose a substantial burden on global populations, requiring innovative broad-spectrum prophylactic and treatment alternatives. Here, we have designed modular synthetic polymer nanoparticles that mimic functional components of host cell membranes, yielding multivalent nanomimics that act by directly binding to varied pathogens. Nanomimic blood circulation time was prolonged by reformulating polymer-lipid hybrids. Femtomolar concentrations of the polymer nanomimics were sufficient to inhibit herpes simplex virus type 2 (HSV-2) entry into epithelial cells, while higher doses were needed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Given their observed virustatic mode of action, the nanomimics were also tested with malaria parasite blood-stage merozoites, which lose their invasive capacity after a few minutes. Efficient inhibition of merozoite invasion of red blood cells was demonstrated both in vitro and in vivo using a preclinical rodent malaria model. We envision these nanomimics forming an adaptable platform for developing pathogen entry inhibitors and as immunomodulators, wherein nanomimic-inhibited pathogens can be secondarily targeted to sites of immune recognition | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Blight, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Ducker, Catherine B |e verfasserin |4 aut | |
| 700 | 1 | |a Gasbarri, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Jonathan C |e verfasserin |4 aut | |
| 700 | 1 | |a Che, Junyi |e verfasserin |4 aut | |
| 700 | 1 | |a Høgset, Håkon |e verfasserin |4 aut | |
| 700 | 1 | |a Saunders, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Ojansivu, Miina |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Zixuan |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Yiyang |e verfasserin |4 aut | |
| 700 | 1 | |a Yeow, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Rifaie-Graham, Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Potter, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Tonkin, Renée |e verfasserin |4 aut | |
| 700 | 1 | |a Penders, Jelle |e verfasserin |4 aut | |
| 700 | 1 | |a Doutch, James J |e verfasserin |4 aut | |
| 700 | 1 | |a Georgiadou, Athina |e verfasserin |4 aut | |
| 700 | 1 | |a Barriga, Hanna M G |e verfasserin |4 aut | |
| 700 | 1 | |a Holme, Margaret N |e verfasserin |4 aut | |
| 700 | 1 | |a Cunnington, Aubrey J |e verfasserin |4 aut | |
| 700 | 1 | |a Bugeon, Laurence |e verfasserin |4 aut | |
| 700 | 1 | |a Dallman, Margaret J |e verfasserin |4 aut | |
| 700 | 1 | |a Barclay, Wendy S |e verfasserin |4 aut | |
| 700 | 1 | |a Stellacci, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Baum, Jake |e verfasserin |4 aut | |
| 700 | 1 | |a Stevens, Molly M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ACS central science |d 2015 |g 8(2022), 9 vom: 28. Sept., Seite 1238-1257 |w (DE-627)NLM251686884 |x 2374-7943 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2022 |g number:9 |g day:28 |g month:09 |g pages:1238-1257 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1021/acscentsci.1c01368 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2022 |e 9 |b 28 |c 09 |h 1238-1257 | ||